<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2023.1253725</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Neuroendocrine research in health and disease, volume II</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname> <given-names>Yu-Feng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c004"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/319898/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kendrick</surname> <given-names>Keith Maurice</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/78919/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chen</surname> <given-names>Xue Qun</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/501791/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sha</surname> <given-names>Lei</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c003"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/524051/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>MOE Key Laboratory for Neuroinformation, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neurology of Second Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou</institution>, <addr-line>Zhejiang</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Neuroendocrine Pharmacology, School of Pharmacy, China Medical University</institution>, <addr-line>Shenyang</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Hubert Vaudry, Universit&#x000E9; de Rouen, France</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Xue Qun Chen <email>chewyg&#x00040;zju.edu.cn</email></corresp>
<corresp id="c002">Keith Maurice Kendrick <email>k.kendrick.uestc&#x00040;gmail.com</email></corresp>
<corresp id="c003">Lei Sha <email>lsha&#x00040;cmu.edu.cn</email></corresp>
<corresp id="c004">Yu-Feng Wang <email>20231059&#x00040;zcmu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1253725</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 Wang, Kendrick, Chen and Sha.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Wang, Kendrick, Chen and Sha</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/30427/neuroendocrine-research-in-health-and-disease-volume-ii" ext-link-type="uri">Editorial on the Research Topic <article-title>Neuroendocrine research in health and disease, volume II</article-title></related-article>
<kwd-group>
<kwd>endocrine</kwd>
<kwd>hormone</kwd>
<kwd>hypothalamus</kwd>
<kwd>neuropeptide</kwd>
<kwd>pituitary</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="21"/>
<page-count count="3"/>
<word-count count="2083"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuroendocrine Science</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In this 2nd volume of &#x0201C;Neuroendocrine Research in Health and Disease&#x0201D;, we collected papers of neuroendocrine research in the following themes.</p>
<sec id="s1">
<title>1. Mental health and behaviors</title>
<p>Mental health and behaviors are closely associated with balanced actions of hormones that are under the control of neuroendocrine activity (Prencipe et al., <xref ref-type="bibr" rid="B15">2023</xref>). Some patients present extremely difficult and challenging behaviors due to brief stressors in life or changes in neural structures in association with neuroendocrine disorders involving oxytocin (Le et al., <xref ref-type="bibr" rid="B8">2022</xref>), arginine vasopressin (Parker et al., <xref ref-type="bibr" rid="B12">2019</xref>), and corticosteroids (Chen, <xref ref-type="bibr" rid="B6">2022</xref>). In this topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2023.1148971">Li et al.</ext-link> presented that individuals with obsessive-compulsive disorder have biomarkers like docosapentaenoic acid and 5-hydroxytryptophan, which help obsessive-compulsive disorder identification and prediction of sertraline treatment outcome, respectively.</p></sec>
<sec id="s2">
<title>2. Neurodegenerative disorders</title>
<p>Neurodegenerative diseases are caused by loss of functions or death of cells in the brain and spinal cord because of genetic mutation, alcoholism, tumor, traumatic injuries, toxins, chemicals, and viruses. The diseases frequently get worse over time and lack efficient therapy (Amanollahi et al., <xref ref-type="bibr" rid="B1">2023</xref>). Sex steroids have been shown to play a role in the progression of specific forms of neurodegenerative diseases (Saleh et al., <xref ref-type="bibr" rid="B18">2023</xref>; Terrin et al., <xref ref-type="bibr" rid="B19">2023</xref>). In this topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2023.1117584">Hu et al.</ext-link> further explored the mechanisms underlying estrogen reduction-associated higher incidence of Alzheimer&#x00027;s disease in women than in men during aging. That is, the higher prevalence of Alzheimer&#x00027;s disease in women is related to changes in brain levels of estrogen that reduce &#x003B2;-amyloid levels, possibly by increasing early growth response-1-stimulated acetylcholinesterase expression.</p></sec>
<sec id="s3">
<title>3. Seizures</title>
<p>Seizure can result from a genetic disorder or an acquired brain injury that are usually localized and from high fevers, alcohol or drug withdrawal, and low blood sugar that affect whole body. When some neurons become excited abnormally, they cause excitation of neurons in their adjacent regions or associated neural networks (Reddy, <xref ref-type="bibr" rid="B16">2020</xref>). In this topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.1056706">He et al.</ext-link> reported that pilocarpine-induced seizures can selectively activate the hypothalamic orexinergic but not melanin-concentrating hormone neurons in rats with sleep disorders, which involves the spread of epileptic activity from amygdala to the hypothalamus, thereby contributing to the disturbance of sleep-wakefulness in temporal lobe epilepsy.</p></sec>
<sec id="s4">
<title>4. Neural regulation of neuroendocrine activity</title>
<p>Neuroendocrine activity is regulated by neural and humoral factors, including autonomic nerve activity (Besecker et al., <xref ref-type="bibr" rid="B3">2018</xref>; Breit et al., <xref ref-type="bibr" rid="B5">2018</xref>; Bonaz, <xref ref-type="bibr" rid="B4">2022</xref>). For example, both intrapancreatic ganglia and extrapancreatic nerves have an important influence on pancreatic endocrine function (Li et al., <xref ref-type="bibr" rid="B9">2019</xref>). In this topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2022.1000758">Zhu et al.</ext-link> further explored that stimulating the cutaneous receptive field formed by the auricular branch of the vagal nerve in the outer ear helps alleviate maladaptive neural plasticity underlying the pathology of several pediatric neurodevelopmental and psychiatric disorders, such as autism spectrum disorder, attention deficit hyperactivity disorder, disruptive behavioral disorder, and stress-related disorder. Thus, this technique provides a promising alternative treatment for pediatric disorders which do not respond to other interventions.</p></sec>
<sec id="s5">
<title>5. Therapeutic usage in endocrine diseases</title>
<p>Many endocrine diseases can be treated with hormones. Hormone replacement therapy (HRT) in aged women has a long history to improve menopausal symptoms while many other health issues like Alzheimer&#x00027;s dementia (Saleh et al., <xref ref-type="bibr" rid="B18">2023</xref>) can also be relieved by HRT. In this topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2022.877715">Kawahara et al.</ext-link> reported the application of HRT in patients with generalized anhidrosis caused by hypothalamic pituitary germinoma. Patients with anhidrosis were diagnosed with germinoma based on magnetic resonance imaging and pituitary biopsy findings, in which panhypopituitarism was identified. Desmopressin, a synthetic analog of arginine vasopressin, resolved the dehydration symptoms, the efficiency of which is associated with the extent of hypothalamic involvement (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2022.877715">Kawahara et al.</ext-link>). The study on this rare sweating disease provides novel pathological mechanism underlying the &#x0201C;diabetes insipidus&#x0201D; and its optimal therapy.</p></sec>
<sec id="s6">
<title>6. Anti-microbial infection</title>
<p>Many studies have revealed that neuropeptides have antimicrobial properties (Aresti Sanz and El Aidy, <xref ref-type="bibr" rid="B2">2019</xref>; Pascal et al., <xref ref-type="bibr" rid="B13">2022</xref>). For example, arginine vasopressin can decrease sepsis-induced pulmonary inflammation, and modulate stress responses by changing cytokine expression and release from immune cells (Russell and Walley, <xref ref-type="bibr" rid="B17">2010</xref>). Oxytocin antagonism promotes replication and translation of hepatitis C virus (Zhu et al., <xref ref-type="bibr" rid="B21">2017</xref>). In this topic, the antimicrobial capacity of hormones is further explored in the treatment and prevention of COVID-19. It is known that COVID-19 caused by severe acute respiratory syndrome coronavirus 2 and that many hormones have been identified as potential agents for treating COVID-19 diseases. Among them, oxytocin possibly inactivates the spike protein of this virus and blocks viral entry into cells via angiotensin-converting enzyme 2 through multiple approaches. In addition, oxytocin can also reduce viral density on the surface of body by increasing parasympathetic outflow and the secretion of body fluids (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2022.799521">Wang et al.</ext-link>). This review provides medical workers a new strategy dealing with COVID-19 and other infectious diseases.</p></sec>
<sec id="s7">
<title>7. Conclusion and perspectives</title>
<p>As a whole, neuroendocrine research provides novel view of neuroendocrine regulation of social and non-social behaviors, cognition and a variety of body functions by hormonal actions via endocrine, autocrine, paracrine and intracrine routes. Thus, they play dominant roles in shaping normal life activity. By contrast, abnormal expression and malfunction of these neuropeptides underlie many diseases including but not limited to stress, hyperthyroidism, infertility, hypertension, hyponatremia, obesity, diabetes mellitus, breastfeeding failure, intellectual disability, psychiatric disorders, metabolic disorders as well as increased susceptibility to tumors and infectious diseases.</p>
<p>Future directions in neuroendocrine studies may include analyzing functions and regulation of classical neuropeptides and hormones, identifying and characterizing novel neuropeptides, exploring cellular and molecular mechanisms underlying neuropeptide actions, constructing the integration center for instinctive behaviors, establishing microbe-gut-brain axis. Certainly, application of modern biomedical techniques such as magnetic resonance imaging (Chen et al., <xref ref-type="bibr" rid="B7">2023</xref>), whole-brain mapping of neuropeptide projections (Zhang et al., <xref ref-type="bibr" rid="B20">2021</xref>; Lin et al., <xref ref-type="bibr" rid="B10">2023</xref>), optogenetics (Perkinson et al., <xref ref-type="bibr" rid="B14">2021</xref>; Pan et al., <xref ref-type="bibr" rid="B11">2022</xref>), in neuroendocrine research is also highly expected.</p></sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>Y-FW: Conceptualization, Resources, Validation, Writing&#x02014;first draft and editing. KK: Conceptualization, Resources, Validation, Writing&#x02014;review and editing. XC: Conceptualization, Resources, Validation, Writing&#x02014;review and editing. LS: Conceptualization, Resources, Validation, Writing&#x02014;review and editing.</p>
</sec>
</body>
<back>
<ack><p>We thank Hubert Vaudry and Dragos Cretoiu for participation in the editorial process and many reviewers for their dedication to ensuring the quality of our accepted papers.</p>
</ack>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amanollahi</surname> <given-names>M.</given-names></name> <name><surname>Jameie</surname> <given-names>M.</given-names></name> <name><surname>Heidari</surname> <given-names>A.</given-names></name> <name><surname>Rezaei</surname> <given-names>N.</given-names></name></person-group> (<year>2023</year>). <article-title>The dialogue between neuroinflammation and adult neurogenesis: mechanisms involved and alterations in neurological diseases</article-title>. <source>Mol. Neurobiol.</source> <volume>60</volume>, <fpage>923</fpage>&#x02013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-022-03102-z</pub-id><pub-id pub-id-type="pmid">36383328</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aresti Sanz</surname> <given-names>J.</given-names></name> <name><surname>El Aidy</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response</article-title>. <source>Psychopharmacology</source> <volume>236</volume>, <fpage>1597</fpage>&#x02013;<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-019-05224-0</pub-id><pub-id pub-id-type="pmid">30997526</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besecker</surname> <given-names>E. M.</given-names></name> <name><surname>White</surname> <given-names>A. R.</given-names></name> <name><surname>Holmes</surname> <given-names>G. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Diminished gastric prokinetic response to ghrelin in a rat model of spinal cord injury</article-title>. <source>Neurogastroenterol. Motil.</source> <volume>30</volume>, <fpage>e13258</fpage>. <pub-id pub-id-type="doi">10.1111/nmo.13258</pub-id><pub-id pub-id-type="pmid">29205695</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonaz</surname> <given-names>B.</given-names></name></person-group> (<year>2022</year>). <article-title>Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction</article-title>. <source>Neurogastroenterol. Motil.</source> <volume>34</volume>, <fpage>e14456</fpage>. <pub-id pub-id-type="doi">10.1111/nmo.14456</pub-id><pub-id pub-id-type="pmid">36097404</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breit</surname> <given-names>S.</given-names></name> <name><surname>Kupferberg</surname> <given-names>A.</given-names></name> <name><surname>Rogler</surname> <given-names>G.</given-names></name> <name><surname>Hasler</surname> <given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Vagus nerve as modulator of the brain-gut axis in psychiatric and inflammatory disorders</article-title>. <source>Front. Psychiatry</source> <volume>9</volume>, <fpage>44</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2018.00044</pub-id><pub-id pub-id-type="pmid">29593576</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X. Q.</given-names></name></person-group> (<year>2022</year>). <article-title>Functional diversity of corticotropin-releasing hormone</article-title>. <source>Nat. Rev. Endocrinol.</source> <volume>18</volume>, <fpage>333</fpage>. <pub-id pub-id-type="doi">10.1038/s41574-022-00663-w</pub-id><pub-id pub-id-type="pmid">35314797</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zou</surname> <given-names>H.</given-names></name> <name><surname>Hou</surname> <given-names>X.</given-names></name> <name><surname>Lan</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Qing</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Oxytocin administration enhances pleasantness and neural responses to gentle stroking but not moderate pressure social touch by increasing peripheral concentrations</article-title>. <source>Elife</source> <volume>12</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.7554./eLife.85847.sa2</pub-id><pub-id pub-id-type="pmid">37171081</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name> <name><surname>Zhu</surname> <given-names>S.</given-names></name> <name><surname>Lan</surname> <given-names>C.</given-names></name> <name><surname>Kou</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Infrequent intranasal oxytocin followed by positive social interaction improves symptoms in autistic children: a pilot randomized clinical trial</article-title>. <source>Psychother. Psychosom.</source> <volume>91</volume>, <fpage>335</fpage>&#x02013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1159/000524543</pub-id><pub-id pub-id-type="pmid">35545057</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Yu</surname> <given-names>G.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Sha</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Intrapancreatic ganglia and neural regulation of pancreatic endocrine secretion</article-title>. <source>Front. Neurosci.</source> <volume>13</volume>, <fpage>21</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00021</pub-id><pub-id pub-id-type="pmid">30842720</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>W.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Zheng</surname> <given-names>Y.</given-names></name> <name><surname>An</surname> <given-names>S.</given-names></name> <name><surname>Zhao</surname> <given-names>M.</given-names></name> <name><surname>Hu</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Whole-brain mapping of histaminergic projections in mouse brain</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>. 120, e2216231120. <pub-id pub-id-type="doi">10.1073/pnas.2216231120</pub-id><pub-id pub-id-type="pmid">36976764</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>L.</given-names></name> <name><surname>Zheng</surname> <given-names>L.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Zhu</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Lu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>A short period of early life oxytocin treatment rescues social behavior dysfunction via suppression of hippocampal hyperactivity in male mice</article-title>. <source>Mol. Psychiatry</source> <volume>27</volume>, <fpage>4157</fpage>&#x02013;<lpage>4171</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-022-01692-7</pub-id><pub-id pub-id-type="pmid">35840800</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname> <given-names>K. J.</given-names></name> <name><surname>Oztan</surname> <given-names>O.</given-names></name> <name><surname>Libove</surname> <given-names>R. A.</given-names></name> <name><surname>Mohsin</surname> <given-names>N.</given-names></name> <name><surname>Karhson</surname> <given-names>D. S.</given-names></name> <name><surname>Sumiyoshi</surname> <given-names>R. D.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism</article-title>. <source>Sci. Transl. Med.</source> <volume>11</volume>, <fpage>7356</fpage>. <pub-id pub-id-type="doi">10.1126./scitranslmed.aau7356</pub-id><pub-id pub-id-type="pmid">31043522</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pascal</surname> <given-names>M.</given-names></name> <name><surname>Kazakov</surname> <given-names>A.</given-names></name> <name><surname>Chevalier</surname> <given-names>G.</given-names></name> <name><surname>Dubrule</surname> <given-names>L.</given-names></name> <name><surname>Deyrat</surname> <given-names>J.</given-names></name> <name><surname>Dupin</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>The neuropeptide VIP potentiates intestinal innate type 2 and type 3 immunity in response to feeding</article-title>. <source>Mucosal. Immunol.</source> <volume>15</volume>, <fpage>629</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1038/s41385-022-00516-9</pub-id><pub-id pub-id-type="pmid">35501356</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perkinson</surname> <given-names>M. R.</given-names></name> <name><surname>Kim</surname> <given-names>J. S.</given-names></name> <name><surname>Iremonger</surname> <given-names>K. J.</given-names></name> <name><surname>Brown</surname> <given-names>C. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Visualising oxytocin neurone activity <italic>in vivo</italic>: the key to unlocking central regulation of parturition and lactation</article-title>. <source>J. Neuroendocrinol.</source> <volume>33</volume>, <fpage>e13012</fpage>. <pub-id pub-id-type="doi">10.1111/jne.13012</pub-id><pub-id pub-id-type="pmid">34289195</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prencipe</surname> <given-names>N.</given-names></name> <name><surname>Marinelli</surname> <given-names>L.</given-names></name> <name><surname>Varaldo</surname> <given-names>E.</given-names></name> <name><surname>Cuboni</surname> <given-names>D.</given-names></name> <name><surname>Berton</surname> <given-names>A. M.</given-names></name> <name><surname>Bioletto</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Isolated anterior pituitary dysfunction in adulthood</article-title>. <source>Front. Endocrinol.</source> <volume>14</volume>, <fpage>1100007</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2023.1100007</pub-id><pub-id pub-id-type="pmid">36967769</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>D. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Brain structural and neuroendocrine basis of sex differences in epilepsy</article-title>. <source>Handb. Clin. Neurol.</source> <volume>175</volume>, <fpage>223</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-64123-6.00016-3</pub-id><pub-id pub-id-type="pmid">33008527</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>J. A.</given-names></name> <name><surname>Walley</surname> <given-names>K. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Vasopressin and its immune effects in septic shock</article-title>. <source>J. Innate Immun.</source> <volume>2</volume>, <fpage>446</fpage>&#x02013;<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1159/000318531</pub-id><pub-id pub-id-type="pmid">20606409</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname> <given-names>R. N. M.</given-names></name> <name><surname>Hornberger</surname> <given-names>M.</given-names></name> <name><surname>Ritchie</surname> <given-names>C. W.</given-names></name> <name><surname>Minihane</surname> <given-names>A. M.</given-names></name></person-group> (<year>2023</year>). <article-title>Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer&#x00027;s Disease (EPAD) cohort</article-title>. <source>Alzheimers. Res. Ther.</source> <volume>15</volume>, <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-022-01121-5</pub-id><pub-id pub-id-type="pmid">36624497</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terrin</surname> <given-names>F.</given-names></name> <name><surname>Tesoriere</surname> <given-names>A.</given-names></name> <name><surname>Plotegher</surname> <given-names>N.</given-names></name> <name><surname>Dalla Valle</surname> <given-names>L.</given-names></name></person-group> (<year>2023</year>). <article-title>Sex and brain: the role of sex chromosomes and hormones in brain development and parkinson&#x00027;s disease</article-title>. <source>Cells</source> <volume>12</volume>, <fpage>486</fpage>. <pub-id pub-id-type="doi">10.3390./cells12111486</pub-id><pub-id pub-id-type="pmid">37296608</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Qiu</surname> <given-names>L.</given-names></name> <name><surname>Xiao</surname> <given-names>W.</given-names></name> <name><surname>Ni</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Reconstruction of the hypothalamo-neurohypophysial system and functional dissection of magnocellular oxytocin neurons in the brain</article-title>. <source>Neuron</source> <volume>109</volume>, <fpage>331</fpage>-346 e337. <pub-id pub-id-type="doi">10.1016/j.neuron.10,032</pub-id>.<pub-id pub-id-type="pmid">33212012</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>P.</given-names></name> <name><surname>Yang</surname> <given-names>N.</given-names></name> <name><surname>Liu</surname> <given-names>R.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Dai</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Establishment and application of a high throughput screening system targeting the interaction between HCV internal ribosome entry site and human eukaryotic translation initiation factor 3</article-title>. <source>Front. Microbiol</source>. 8, 977. <pub-id pub-id-type="doi">10.3389/fmicb.2017.00977</pub-id><pub-id pub-id-type="pmid">28611766</pub-id></citation></ref>
</ref-list>
</back>
</article>